International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Aug 1968, following a joint meeting of H-XH2352 - Groupement international de l'industrie pharmaceutique des pays de la CEE (GIIP) and U-XH3131 - Pharmaceutical Industries' Association in the EFTA (PIA), with Pharmaceutical Manufacturers Association (PMA) of the United States and Pharmaceutical Manufacturers Association of Canada (PMAC), Jun 1968, Stockholm (Sweden). Previously also referred to in French and Spanish as Fédération internationale de l'industrie du médicament (FIIM) -- Federación Internacional de la Industria del Medicamento (FIIM).
Engage with international organizations to build mutual understanding and find effective and sustainable solutions to major global health issues with a focus on medicines quality, innovation and access.
Events31 past events available with paid subscription only.
ActivitiesAvailable with paid subscription only.
General Assembly (every 2 years). Council (meeting biannually), including President, 2 Vice-Presidents, 20 representatives from member associations and 19 representatives from member companies. Committees (4). Secretariat in Geneva (Switzerland), headed by Director General.
LanguagesAvailable with paid subscription only.
StaffAvailable with paid subscription only.
FinanceAvailable with paid subscription only.
Consultative StatusAvailable with paid subscription only.
Relations with Inter-Governmental OrganizationsAvailable with paid subscription only.
Relations with Non-Governmental OrganizationsAvailable with paid subscription only.
PublicationsAvailable with paid subscription only.
MembersAvailable with paid subscription only.
Type I ClassificationAvailable with paid subscription only.
Type II ClassificationAvailable with paid subscription only.
Subjects *Available with paid subscription only.
UIA Org ID
** UN SDGs are linked to the subject classification.
← return to your search page to find additional profiles.
UIA allows users to access and make use of the information contained in its Databases for the user’s internal use and evaluation purposes only. A user may not re-package, compile, re-distribute or re-use any or all of the UIA Databases or the data* contained therein without prior permission from the UIA.
Data from database resources may not be extracted or downloaded in bulk using automated scripts or other external software tools not provided within the database resources themselves. If your research project or use of a database resource will involve the extraction of large amounts of text or data from a database resource, please contact us for a customized solution.
UIA reserves the right to block access for abusive use of the Database.
* Data shall mean any data and information available in the Database including but not limited to: raw data, numbers, images, names and contact information, logos, text, keywords, and links.